Table 4.
Characteristics of patients stratified by non-fatal/fatal cases and severity during hospitalisation
| Nonfatal (n=3129) | Fatal (n=243) |
No oxygen (n=1988) |
Oxgen (n=1035) |
IMV/ECMO (n=353) |
|
| Fatal cases | 6 (0) | 137 (13) | 100 (28) | ||
| Severity on admission | |||||
| Nonsevere | 2155 (69) | 39 (16) | 1796 (90) | 357 (35) | 43 (12) |
| Severe | 974 (31) | 204 (84) | 192 (10) | 678 (66) | 310 (88) |
| Worst severity during hospitalisation | |||||
| No oxygen | 1980 (63) | 6 (3) | |||
| Oxygen | 897 (29) | 137 (56) | |||
| IMV/ECMO | 252 (8) | 100 (41) | |||
| Days between onset and admission (median (IQR)) | 7 (4, 10) | 5 (2, 8) | 7 (4, 10) | 6 (3, 9) | 7 (5, 10) |
| Age (median (IQR)) | 54 (40, 68) | 80 (71, 86) | 48 (33, 61) | 68 (53, 80) | 65 (56, 74) |
| Male | 1899 (61) | 161 (66) | 1083 (55) | 694 (67) | 285 (81) |
| BMI (median (IQR)) | 23.3(20.8, 26.3) | 22.7(19.4, 25.7) | 22.6(20.2, 25.5) | 24.0(21.5, 27.0) | 24.8(22.6, 27.8) |
| Cardiovascular disease | 129 (4) | 54 (22) | 48 (2) | 106 (10) | 29 (8) |
| Respiratory disease | 103 (3) | 35 (14) | 29 (2) | 78 (8) | 33 (9) |
| Liver disease | 75 (2) | 13 (5) | 36 (2) | 32 (3) | 20 (6) |
| Cerebrovascular disease | 135 (4) | 51 (21) | 57 (3) | 105 (10) | 25 (7) |
| Asthma | 157 (5) | 9 (4) | 92 (5) | 52 (5) | 22 (6) |
| Diabetes | 475 (15) | 86 (35) | 197 (10) | 244 (24) | 121 (34) |
| Obesity | 169 (5) | 9 (4) | 70 (4) | 75 (7) | 33 (9) |
| Severe renal disease or dialysis | 34 (1) | 13 (5) | 14 (1) | 21 (2) | 12 (3) |
| Solid tumour | 114 (4) | 31 (13) | 60 (3) | 63 (6) | 22 (6) |
| Leukaemia | 9 (0) | 4 (2) | 6 (0) | 7 (1) | 0 (0) |
| Lymphoma | 13 (0) | 12 (5) | 6 (0) | 16 (2) | 3 (1) |
| Hypertension | 551 (18) | 70 (29) | 234 (12) | 274 (27) | 115 (33) |
| Hyperlipidaemia | 305 (10) | 26 (11) | 148 (7) | 124 (12) | 61 (17) |
| Use of steroid in 1 month | 10 (0) | 5 (2) | 4 (0) | 8 (1) | 4 (1) |
| Chemotherapy in 3 months | 38 (1) | 18 (7) | 21 (1) | 30 (3) | 5 (1) |
| Immunosuppressants** use in 3 months | 37 (1) | 7 (3) | 18 (1) | 18 (2) | 8 (2) |
| Fever (≥37.5℃) | 1737 (56) | 199 (82) | 897 (45) | 758 (74) | 285 (82) |
| Cough | 1770 (58) | 112 (52) | 1034 (53) | 643 (64) | 206 (69) |
| Sore throat | 459 (17) | 23 (16) | 316 (18) | 125 (15) | 41 (16) |
| Runny nose | 311 (11) | 13 (7) | 224 (12) | 79 (9) | 22 (8) |
| Chest pain | 136 (5) | 3 (2) | 88 (5) | 46 (6) | 5 (2) |
| Myalgia | 242 (9) | 9 (7) | 148 (8) | 84 (10) | 19 (7) |
| Headache | 486 (18) | 11 (8) | 333 (18) | 138 (17) | 26 (10) |
| Confusion | 60 (2) | 29 (14) | 19 (1) | 54 (6) | 16 (5) |
| Fatigue | 1323 (46) | 104 (62) | 709 (38) | 560 (62) | 160 (58) |
| Abdominal pain | 79 (3) | 5 (3) | 53 (3) | 25 (3) | 6 (2) |
| Vomit | 139 (5) | 8 (5) | 80 (4) | 51 (6) | 16 (6) |
| Diarrhoea | 397 (14) | 18 (9) | 236 (13) | 143 (15) | 36 (13) |
| Dysgeusia | 128 (17) | 25 (10) | 454 (26) | 128 (17) | 25 (10) |
| Dysosmia | 103 (14) | 13 (6) | 402 (23) | 103 (14) | 13 (6) |
*Immunosupprenssants other than steroids.
IMV/ECMO, invasive mechanical ventilation/extracorporeal membrane oxygenation.